A privately-owned Icelandic company established in 2001. ORF Genetics Ltd. is a pioneer in genetic science committed to developing innovative, economically viable and enabling solutions to produce recombinant proteins more efficiently and safely than other protein expression systems. ORF Genetics developed for this purpose the unique expression system Orfeus™ that uses barley grain as a vehicle for recombinant protein production which has proven to be particularly effective in the expression of growth factors and cytokines. ORF has developed a portfolio of growth factors for the stem cell research market, the skin care market and for cultivated meat. ORF Genetics founded ISOKINE™, Endotoxin-free Growth Factors & Cytokines, and can offer lower list prices than market leaders. Standard bioactivity is on par with market leaders. ORF Genetics also founded BIOEFFECT™ when discovering a way to bioengineer a plant-based replica of EGF, a naturally occurring human protein, in barley. BIOEFFECT is an award-winning plant-based anti-ageing skincare range. Used by over 30% of Icelandic women since its launch in 2010. BIOEFFECT is sold in premium stores such as Harrods, Bergdorf Goodman, Harvey Nichols and online, www.bioeffect.com. ORF Genetics researchers are continuously discovering proteins that can be applied in different markets. ORF Genetics' latest project, MESOKINE™, allows ORF Genetics to produce growth factors for cuktivated meat which can revolutionize FoodTech. ORF Genetics ventures into a new market with MESOKINE™, facing one of the world’s most challenging global problems, the environmental, social and ethical impact of the global meat industry.
| Website | https://orfgenetics.com/ |
| Revenue | $6.7 million |
| Employees | 26 (26 on RocketReach) |
| Founded | 2001 |
| Address | Vikurhvarf 7, Kopavogur, Capital Region, IS |
| Phone | (354) 591-1570 |
| Fax | (354) 591-1580 |
| Industry | Biotechnology Research, Biotechnology, Pharmaceuticals, Healthcare |
| Keywords | Recombinant Proteins, Genetic Engineering, Protein Production, Biotechnology, Pharmaceutical Manufacturing, Gene Technology, Therapeutic Proteins, Molecular Biology, Drug Development, Bioprocessing, Bioscience, Life Sciences, Pharmaceutical Research, Protein Engineering, Cell Culture, Gene Expression, Biotechnology Solutions, Innovative Therapeutics |
| Competitors | CSL Behring, Amgen, Biogen, Regeneron, Zymeworks Inc., Aldevron, Sangamo Therapeutics, Inc., Lilly India, Vivo Biosciences , Inc., Geno +42 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular ORF Genetics hf. employee's phone or email?
The ORF Genetics hf. annual revenue was $6.7 million in 2026.
Berglind Olafsdottir is the CEO of ORF Genetics hf..
26 people are employed at ORF Genetics hf..
ORF Genetics hf. is based in Kopavogur, Capital Region.
The NAICS codes for ORF Genetics hf. are [54171, 541713, 54, 541, 5417].
The SIC codes for ORF Genetics hf. are [87, 873].